Back to search

Article

Cardiovascular drugs approved for heart failure with reduced ejection fraction and/or post-myocardial infarction exert consistent effects in both populations: A meta-analysis and meta-regression of randomized controlled trials

2024-02-06

Abstract excerpt

<h4>Background</h4> Heart failure (HF) following an acute myocardial infarction (post-MI HF) has been studied as an additional sub-type of HF to broaden the indications for HF drugs. Post-MI HF and HFrEF are pathophysiologically similar and share pharmacotherapies. In this meta-analysis, we examined the concordance between all-cause mortality data for drugs indicated for HFrEF and post-MI HF. We used our analysis...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
b865bc63-3495-5ee3-a412-43ba06ab9f8d
DOI
10.1101/2024.02.05.24301181
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Cardiovascular drugs approved for heart failure with reduced ejection fraction and/or post-myocardial infarction exert consistent effects in both populations: A meta-analysis and meta-regression of randomized controlled trialsDOI 10.1101/2024.02.05.24301181
Age-adjusted mortality from systolic heart failure (HFrEF) is almost double that of diastolic heart failure (HFpEF) over recent years, with significant racial disparitySemantic proximity
Ventricular remodeling with dapagliflozin in elderly women with HFpEF--a single center prospective studySemantic proximity
Dapagliflozin vs. empagliflozin in patients with chronic heart failure: a single-center registry analysisSemantic proximity
Real-World Effectiveness of SGLT2 Inhibitors Across Heart Failure Phenotypes: A Meta-Analysis.Semantic proximity
Left Ventricular Remodeling Response to SGLT2 inhibitors in Heart Failure: An Updated Meta-analysis of Randomized Controlled StudiesSemantic proximity
Effect of SGLT-2 Inhibitors on Cardiovascular Outcomes Among Patients With Heart Failure and Type 2 Diabetes Mellitus: A Systemic Review and Meta-Analysis of Randomized Controlled TrialsSemantic proximity
Patient-level comparison of heart failure patients in clinical phenotype and prognosis from China and Sweden.Semantic proximity
Comparative Effectiveness of Second-line Antihyperglycemic Agents for Cardiovascular Outcomes: A Large-scale, Multinational, Federated Analysis of the LEGEND-T2DM StudySemantic proximity
Effect of Beta Blockers on Exercise Capacity, Diastolic Function, and Quality of Life in Patients with Heart Failure with Preserved Ejection Fraction: A Secondary Analysis of INDIE-HFpEF and RELAXSemantic proximity
Heart failure with non-reduced ejection fraction: Epidemiology, pathophysiology, phenotypes, diagnosis and treatment approaches.Semantic proximity
Heterogeneous Treatment Effects in HFpEF: Distinguishing Drug-Specific Response from Prognostic Phenotypes Across Randomized TrialsSemantic proximity
Heart failure clinical care analysis uncovers risk reduction opportunities for preserved ejection fraction subtype.Semantic proximity
Select a neighboring publication to make it the new centre.